Navigation Links
Thomson Reuters Announces 2009 Edition of the CMR International Pharmaceutical R&D Factbook
Date:7/22/2009

PHILADELPHIA and LONDON, July 22 /PRNewswire/ -- The 2009 edition of the trusted and often cited compendium of pharmaceutical research and development statistics, the CMR International Pharmaceutical R&D Factbook, is now available. This year's Factbook offers extended content including patent information and emerging trends in worldwide pharmaceutical R&D.

"The R&D Factbook provides the data that R&D companies need to make informed decisions," said Dr. Jane Sharples, General Manager of CMR International. "With this publication, R&D companies can gain insights into industry dynamics and trends, determine how they perform against the market as a whole and gauge their productivity in relation to their peers and competitors. Companies can also see the consequences of adopting different R&D strategies. In short, they have accurate, independent and validated information on which to base business decisions."

Highlights of the 2009 edition include:

  • The number of new molecular entities (NME) launched onto the global market failed to improve on 2008's 20-year low. Actual development times for new molecular entities are slowly increasing to 14 years, though major pharmaceutical companies (those that spent more than $2 billion on R&D in 2008) take on average slightly more than 11 years.
  • Anti-cancer therapy is the most common area for new patent filing on emerging targets.
  • India leads the way in the recent trend towards new molecular entity research by generic specialty companies.

The Centre for Medicines Research International Ltd (CMR International), a Thomson Reuters business, yearly publishes the Factbook. This is an up-to-date business planning tool for decision makers in the pharmaceutical industry, including R&D, corporate finance, business strategy, marketing pla
'/>"/>

SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
2. Thomson Scientific to Host Pharmaceutical Vision - A Users Conference for Information, Regulatory Affairs, Competitive Intelligence and Biotechnology Professionals
3. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
4. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
5. Thomson Scientific Begins Expansion of Web of Science
6. Thomson Reuters Launches New Biomarkers Solution
7. The Scientific Business of Thomson Reuters Publishes Its 2008 Liquent Regulatory Affairs Trends Survey Results
8. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
9. Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
10. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
11. APS Healthcare and Thomson Reuters to Manage New York States Medicaid Clinical Best Practices Review Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 4, 2015  Traverse Biosciences announced today that ... development agreement (CRADA) with Aratana Therapeutics Inc. (NASDAQ: ... TRB-N0224 for the treatment and control of periodontal ... Traverse Biosciences has also granted Aratana an exclusive ... control of periodontal disease in companion animals, inclusive ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Achieved primarily ... produces slides that boast 10 to 100x better detail ... the capabilities of all existing light microscopy methods, it ... micrographs were chosen as the frame of reference because ... , The goal from the earliest discovery days ...
(Date:5/4/2015)... --  Intrexon Corporation (NYSE: XON ) today ... after the market closes on May 11, 2015.  The ... 5:30 PM ET to discuss the results and provide ... may be accessed by dialing 1-888-346-3959 (Domestic US) and ... Call."  Participants may also access the live webcast through ...
(Date:5/1/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), ... it has priced an underwritten registered offering of 3,900,000 ... $9.00 per share, and granted the underwriters in the ... additional 585,000 shares of its common stock. The gross ... is expected to close on May 6, 2015, subject ...
Breaking Biology Technology:Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4Intrexon to Announce First Quarter 2015 Financial Results on Monday, May 11, 2015 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3
... Brownstein, Art Director at CONNEXION Healthcare (CXHC), ... by the Healthcare Businesswomen,s Association (HBA). HBA ... sectors of the healthcare industry, including pharmaceutical, ... market research. Nominated by HBA,s corporate members, ...
... Calif., Feb. 18 Amgen Inc. (Nasdaq: ... Drug Administration (FDA) has accepted Amgen,s submission and filed ... RANK Ligand inhibitor. The indications for which Amgen ... postmenopausal osteoporosis (PMO) in women and treatment and prevention ...
... Speed up the Peer Review Process!COLUMBIA, S.C., ... Bulletin Board: CLXS), a leading developer of ... today that the American Association for Cancer ... Finder and Journal Dashboard applications for the ...
Cached Biology Technology:Jennifer Brownstein, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 2FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 3FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 4FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 5FDA Accepts Amgen's Submission and Files Biologics License Application for Denosumab 6American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 2American Association for Cancer Research (AACR) Deploys Collexis' Reviewer Finder and Journal Dashboard Applications 3
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)... YORK , March 31, 2015   Guidepoint ... the launch of the Post-Surgical Pain Management TRACKER, part ... products tracking usage trends in the medical device and ... access to data including treatment volumes, market share, and ... the pain associated with joint surgery. The ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... a negative view of climate engineering, the deliberate large-scale ... to a new study. The results are from ... (New Zealand) who have undertaken the first systematic large-scale ... The work is published in Nature Climate ...
... announced today the purchase of an Irys ™ System ... genome assembly of Aegilops tauschii, one of three progenitors ... led by Dr. Jan Dvorak , will use the Irys ... orientation of all genes and transposable elements of the A. ...
... of Nottingham have discovered a key difference in the biological ... bacterial pathogens. The study, published in the journal ... the University,s School of Life Sciences, centred on STAT1, a ... role in regulating genes in the body. STAT-1 responds ...
Cached Biology News:Climate engineering -- what do the public think? 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 2UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 3UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 4UC Davis Purchases Irys System From BioNano Genomics To Advance Genome Mapping And Assembly Of Wheat Relative 5Research uncovers key difference between our bodies' fight against viruses and bacteria 2